Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial
jene aus dem Jahr 2013, die im New England Journal of Medicine verffentlicht wurde
Purser A personalized review of your results with expert interpretation and nextstep guidance
It helps neutralize free radicals that cause cellular aging, inflammation, and chronic disease
It wins on the total picture: no membership fee, no price increase when your dose goes up, no hidden fees, transparent and clean pharmacy credentials, human support that answers within hours, and FedEx next-day air shipping
ISBN 978-0-12-420118-7